09:04 AM EDT, 03/13/2025 (MT Newswires) -- VolitionRx ( VNRX ) said Thursday it has extended its Nu.Q Vet Cancer Test supply deal with Fujifilm Vet Systems in Japan for a new five-year initial term to include the chemiluminescent immunoassay version of the test through an automated analyzer platform.

The agreement previously allowed Fujifilm to provide the test to Japanese veterinarians in a manual format, VolitionRx ( VNRX ) said.

Fujifilm will work with VolitionRx ( VNRX ) for the final validation and verification of the automated platform for canine cancer screening for a launch in the summer, according to VolitionRx ( VNRX ).